SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The REGAL Phase 3 trial reaching its 80-death threshold has put final analysis and GPS survival results in focus. Traders are debating the sharp selloff since the milestone: bullish holders view it as volatility ahead of the readout, while bearish voices warn the results could disappoint; claims of manipulation or a data leak remain speculation.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with investors focused on dilution, the purchase price and the long wait for completion as MRVL and LITE shares fall. Some traders see the deal as an overreach that could weigh on shareholders, while others view combining Marvells connectivity chips with Lumentums optical technology as a strategic bet on AI data centers.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum is the main focus, with traders questioning why LITE is falling despite the announced premium. Debate centers on the fixed share exchange tying LITEs value to Marvells stock and the long, approval-dependent closing process; some see strategic value in combining AI networking and optics, while others view the terms as unfavorable to shareholders.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is drawing attention ahead of its Q3 report after a sharp semiconductor-sector selloff following Intels weak outlook, which traders debate as either Intel-specific or a warning about PC/server demand and AI infrastructure returns. Bulls point to AMDs data-center and AI exposure as a differentiator, while skeptics worry about high expectations and the risk of disappointing guidance.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is drawing attention after UBS upgraded the stock to Buy, framing its recent selloff as a buying opportunity ahead of the R2 ramp. Traders are broadly reacting to the rally with bullish talk of a rebound and possible short covering, while some caution that execution and persistent losses matter more than an analyst upgrade.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond fundraising to finance its AI infrastructure buildout is the dominant focus, with traders linking the sharp selloff to dilution, added debt and doubts about when heavy spending will pay off. Some argue the financing was already disclosed and supports growth, while others see the timing and capital needs as signs of mounting risk.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Attention centers on speculation over when Compass will complete its rolling NDA submission for COMP360 and what the FDA review timeline may mean for the treatments path to market; uncertainty around the update is adding to frustration over the share decline. Usonas separate psilocybin filing has prompted some competitive concern, while other traders argue its MDD focus and nonprofit structure make it a different challenge for Compasss TRD program.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes quarterly results showed strong revenue growth and an improved loss, but shares sold off sharply as investors focused on the lack of quantified guidance, high costs, and uncertainty around the Alzheimers agitation launch and path to profitability. Traders are split between viewing Auvelitys growth as evidence of a solid business and seeing managements limited outlook as a source of continued uncertainty.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazons post-earnings rebound is drawing attention after the initial selloff over heavy AI spending and cash-flow concerns. Traders are split between viewing the drop as an overreaction given accelerating AWS growth and demand, and questioning when the investment will generate returns.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstarts continued slide to fresh 52-week lows is being linked by traders to concerns about its debt and funding needs, rising yields, and the companys sensitivity to borrowing costs; some also blame persistent short selling and weak institutional demand. The mood is largely bearish and frustrated, though some traders see oversold conditions and high short interest as potential fuel for a rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
